Bicycle Therapeutics
(NASDAQ:BCYC)
$24.90
0.35[1.43%]
At close: Mar 28
$24.90
0[0.00%]
After Hours: 6:22PM EDT
Consensus Rating1
Buy
Highest Price Target1
$65.00
Lowest Price Target1
$30.00
Consensus Price Target1
$42.88

Bicycle Therapeutics Stock (NASDAQ:BCYC), Analyst Ratings, Price Targets, Predictions

Bicycle Therapeutics PLC has a consensus price target of $42.88, established from looking at the 56 latest analyst ratings. The last 3 analyst ratings were released from Canaccord Genuity, HC Wainwright & Co., and Needham on February 21, 2024. With an average price target of $52.67 between Canaccord Genuity, HC Wainwright & Co., and Needham, there's an implied 111.51% upside for Bicycle Therapeutics PLC from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
1
1
Dec 23
1
Feb
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Canaccord Genuity
HC Wainwright & Co.
Needham
JMP Securities
Cantor Fitzgerald

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Bicycle Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/21/2024BCYCBuy Now
Bicycle Therapeutics
$24.90140.96%Canaccord Genuity
Bill Maughan
→ $60ReiteratesBuy → BuyGet Alert
02/21/2024BCYCBuy Now
Bicycle Therapeutics
$24.90120.88%HC Wainwright & Co.
Swayampakula Ramakanth
$57 → $55MaintainsBuyGet Alert
02/21/2024BCYCBuy Now
Bicycle Therapeutics
$24.9072.69%Needham
Ami Fadia
→ $43ReiteratesBuy → BuyGet Alert
12/20/2023BCYCBuy Now
Bicycle Therapeutics
$24.9028.51%JMP Securities
Reni Benjamin
$44 → $32MaintainsMarket OutperformGet Alert
12/15/2023BCYCBuy Now
Bicycle Therapeutics
$24.9072.69%Needham
Ami Fadia
$46 → $43MaintainsBuyGet Alert
11/08/2023BCYCBuy Now
Bicycle Therapeutics
$24.90161.04%Cantor Fitzgerald
Li Watsek
→ $65ReiteratesOverweight → OverweightGet Alert
11/03/2023BCYCBuy Now
Bicycle Therapeutics
$24.9060.64%Morgan Stanley
Jeffrey Hung
$42 → $40MaintainsEqual-WeightGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$24.9032.53%B. Riley Securities
Kalpit Patel
→ $33UpgradeNeutral → BuyGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$24.90161.04%Cantor Fitzgerald
Li Watsek
→ $65ReiteratesOverweight → OverweightGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$24.9076.71%JMP Securities
Reni Benjamin
→ $44ReiteratesMarket Outperform → Market OutperformGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$24.9084.74%Needham
Ami Fadia
→ $46ReiteratesBuy → BuyGet Alert
09/11/2023BCYCBuy Now
Bicycle Therapeutics
$24.9032.53%B. Riley Securities
Kalpit Patel
$33 → $33UpgradeNeutral → BuyGet Alert
09/07/2023BCYCBuy Now
Bicycle Therapeutics
$24.90161.04%Cantor Fitzgerald
Li Watsek
→ $65ReiteratesOverweight → OverweightGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$24.9068.67%Morgan Stanley
Jeffrey Hung
$42 → $42ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$24.9076.71%JMP Securities
Reni Benjamin
$46 → $44MaintainsOutperformGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$24.90128.92%HC Wainwright & Co.
Swayampakula Ramakanth
→ $57ReiteratesBuy → BuyGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$24.9084.74%Needham
Ami Fadia
$48 → $46MaintainsBuyGet Alert
08/03/2023BCYCBuy Now
Bicycle Therapeutics
$24.90100.8%EF Hutton
Tony Butler
→ $50Reiterates → BuyGet Alert
05/11/2023BCYCBuy Now
Bicycle Therapeutics
$24.9084.74%JMP Securities
Reni Benjamin
$46 → $46ReiteratesMarket Outperform → Market OutperformGet Alert

FAQ

Q

What is the target price for Bicycle Therapeutics (BCYC)?

A

The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by Canaccord Genuity on February 21, 2024. The analyst firm set a price target for $60.00 expecting BCYC to rise to within 12 months (a possible 140.96% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bicycle Therapeutics (BCYC)?

A

The latest analyst rating for Bicycle Therapeutics (NASDAQ: BCYC) was provided by Canaccord Genuity, and Bicycle Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Bicycle Therapeutics (BCYC)?

A

The last upgrade for Bicycle Therapeutics PLC happened on September 12, 2023 when B. Riley Securities raised their price target to $33. B. Riley Securities previously had a neutral for Bicycle Therapeutics PLC.

Q

When was the last downgrade for Bicycle Therapeutics (BCYC)?

A

The last downgrade for Bicycle Therapeutics PLC happened on April 13, 2022 when B. Riley Securities changed their price target from $62 to $33 for Bicycle Therapeutics PLC.

Q

When is the next analyst rating going to be posted or updated for Bicycle Therapeutics (BCYC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bicycle Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bicycle Therapeutics was filed on February 21, 2024 so you should expect the next rating to be made available sometime around February 21, 2025.

Q

Is the Analyst Rating Bicycle Therapeutics (BCYC) correct?

A

While ratings are subjective and will change, the latest Bicycle Therapeutics (BCYC) rating was a reiterated with a price target of $0.00 to $60.00. The current price Bicycle Therapeutics (BCYC) is trading at is $24.90, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch